Growth Metrics

Rxo (RXO) Equity Ratio (2021 - 2025)

Rxo (RXO) has disclosed Equity Ratio for 5 consecutive years, with 0.49 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Equity Ratio rose 1.35% year-over-year to 0.49, compared with a TTM value of 0.49 through Sep 2025, up 1.35%, and an annual FY2024 reading of 0.47, up 45.07% over the prior year.
  • Equity Ratio was 0.49 for Q3 2025 at Rxo, down from 0.5 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.52 in Q4 2021 and bottomed at 0.29 in Q4 2022.
  • Average Equity Ratio over 5 years is 0.4, with a median of 0.4 recorded in 2023.
  • The sharpest move saw Equity Ratio crashed 44.14% in 2022, then soared 60.64% in 2024.
  • Year by year, Equity Ratio stood at 0.52 in 2021, then crashed by 44.14% to 0.29 in 2022, then grew by 12.61% to 0.33 in 2023, then skyrocketed by 45.07% to 0.47 in 2024, then rose by 4.54% to 0.49 in 2025.
  • Business Quant data shows Equity Ratio for RXO at 0.49 in Q3 2025, 0.5 in Q2 2025, and 0.48 in Q1 2025.